Biomedical Research - Training, Individual (TR)

Active

Assistance listing
93.GM3
Agency
Grant awards
Not on record

Program facts

Treasury account
  • 75-0897-0-1-552
More information

Program details come from SAM.gov Assistance Listings. Updated .

About this program

The National Institute of General Medical Sciences (NIGMS), an NIH component within the Department of Health and Human Services, administers the Biomedical Research—Training, Individual program (CFDA 93.GM3) to support training of future scientists and research capacity development in basic biomedical research. No recent grant awards or open grant opportunities are present in the source.

The program funds training and capacity-building activities that advance understanding of biological processes and lay the foundation for advances in disease diagnosis, treatment, and prevention. Applicants may pursue support across basic research training initiatives that NIGMS prioritizes within its mission areas.

NIGMS emphasizes strategic portfolio management in funding decisions. The Institute does not operate under a strict payline or score-based cutoff; rather, program staff weigh scientific merit alongside portfolio breadth, investigator status (including early-stage and at-risk investigator priorities), and the applicant's existing funding support. NIGMS explicitly prioritizes funding meritorious investigators without substantial other support over additional grants to already well-funded researchers and generally prioritizes the MIRA program over R01 awards. The Institute considers budget levels carefully and reserves large budget increases for highly compelling cases; applicants should not assume they will receive the full amount recommended by peer review.

Peer review follows NIH standard procedures: all applications undergo initial review for scientific and technical merit, followed by national advisory council review. Applicants may question substantive or procedural aspects of review through NIH Peer Review Appeal procedures documented at https://grants.nih.gov/grants/guide/notice-files/NOT-OD-11-064.html.

Eligible applicants, specific assistance types, award magnitudes, and application deadlines are published in the Notice of Funding Opportunity (NOFO). Recipients must retain expenditure and financial records for three years from submission of the final financial status report and are subject to DHHS and other federal government audits and inspections.

Objective and description

Objective

The National Institute of General Medical Sciences (NIGMS) supports basic research that increases our understanding of biological processes and lays the foundation for advances in disease diagnosis, treatment, and prevention. NIGMS also supports rese

Description

To ensure the vitality and continued productivity of the research enterprise, the National Institute of General Medical Sciences (NIGMS) provides leadership in supporting the training of future scientists and developing research capacity throughout the country.

Eligibility

Applicant eligibility

Description of who is eligible to apply will be published in the NOFO.

How to apply

Criteria for selecting proposals

All accepted applications are reviewed for scientific and technical merit by an appropriate initial review group and by a national advisory council. The goal of NIGMS funding policies is to maximize the scientific impact of investments in investigator-initiated biomedical research to drive fundamental scientific discoveries that advance understanding of human health and disease. To address this goal, the Institute strives to support a broad portfolio of research grants of high scientific and technical merit, as determined by peer review, in its mission areas. However, in deciding to fund any application, NIGMS staff also considers other factors, including (consistent with applicable law): the breadth of the Institute's research portfolio; approaches, and investigators; the total amount of funding available to the investigator; the priority of the research area for the Institute's mission; Early-stage investigator status; At-risk investigator status;and whether the PI would have more than one NIGMS funded R01 (including multi-PI R01s). Because these factors are considered, NIGMS does not have a "payline" or strict cutoff in scores that it will fund. It is important to understand that even applications with outstanding scores might not be funded if the investigator already has substantial other support. Because NIGMS prioritizes funding for meritorious investigators who otherwise would not have support over providing additional grants to already well-funded investigators, the Institute is unlikely to award more than one NIGMS R01 to a PI (including multi-PI R01s). In accordance with our Strategic Plan, NIGMS generally prioritizes funding the MIRA program over R01 awards.

Award procedure

In calculating budgets for grants, NIGMS staff considers each budget carefully and takes into account the science being conducted, the other support for the PI's lab, the Institute's budget, and other factors. PIs should not assume that they will be awarded the amount recommended by the study section. To fund as broad a portfolio of meritorious investigators as soon as possible and to improve overall returns on investments, NIGMS pays close attention to budget levels and gives large budget increases only in highly compelling cases. Applicants are encouraged to contact NIGMS program staff with questions.

Renewals

An applicant may question the substantive or procedural aspects of the review of his/her application by communicating with the staff of the Institute. A description of the NIH Peer Review Appeal procedures is available on the NIH website at https://grants.nih.gov/grants/guide/notice-files/NOT-OD-11-064.html.

Appeals

An applicant may question the substantive or procedural aspects of the review of his/her application by communicating with the staff of the Institute. A description of the NIH Peer Review Appeal procedures is available on the NIH website at https://grants.nih.gov/grants/guide/notice-files/NOT-OD-11-064.html.

Quick answers

What is Assistance Listing 93.GM3?

Assistance Listing 93.GM3 is Biomedical Research - Training, Individual (TR), a federal grant program run by National Institutes of Health (Department of Health and Human Services).

What is the CFDA number for Biomedical Research - Training, Individual (TR)?

Its CFDA number is 93.GM3: Assistance Listing numbers were called CFDA numbers before 2018.

On GovTribe

See this program's full record

  • Every grant award and opportunity under it
  • Funding by recipient, agency and assistance type
  • Alerts for new opportunities
  • Ask GovTribe AI about this program